Cargando…
Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy
Single-component nanomaterials such as bismuth (Bi) based on nanoparticles (NPs) intrinsically having both diagnostic and therapeutic capabilities are widely needed in biomedical fields. However, their design and fabrication still face enormous challenges. Here, a kind of pure Bi NPs with ultrahigh...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517535/ https://www.ncbi.nlm.nih.gov/pubmed/31193098 http://dx.doi.org/10.1016/j.csbj.2019.04.005 |
_version_ | 1783418297152176128 |
---|---|
author | Lu, Shu-Ting Xu, Dan Liao, Ru-Fang Luo, Jia-Zhen Liu, Yu-Hang Qi, Zhen-Hua Zhang, Cai-Ju Ye, Nai-Li Wu, Bo Xu, Hai-Bo |
author_facet | Lu, Shu-Ting Xu, Dan Liao, Ru-Fang Luo, Jia-Zhen Liu, Yu-Hang Qi, Zhen-Hua Zhang, Cai-Ju Ye, Nai-Li Wu, Bo Xu, Hai-Bo |
author_sort | Lu, Shu-Ting |
collection | PubMed |
description | Single-component nanomaterials such as bismuth (Bi) based on nanoparticles (NPs) intrinsically having both diagnostic and therapeutic capabilities are widely needed in biomedical fields. However, their design and fabrication still face enormous challenges. Here, a kind of pure Bi NPs with ultrahigh X-ray attenuation coeffcient was developed and evaluated as a simple but powerful theranostic nanomaterals and potent light-to-heat conversion efficiency for photoacuostic imaging (PAI)/photothermal therapy (PTT) in this study. The prepared pure Bi NPs showed excellent photothermal performance and the temperature of NPs solution (1 mg/mL) increased to 70 °C under near-infrared light irradiation within 4 min. The pure Bi NPs showed obvious enhancement effect both in X-ray computed tomography (CT) and PA imaging modalities in vivo. In addition, the glioma growth was efficiently suppressed by the pure Bi NPs after 808 nm laser irradiation, while maintained the biosafety and low toxicity. Thus, it is notable that this type of Bi nanomaterial has great potential in multi-imaging guided cancer treatment. |
format | Online Article Text |
id | pubmed-6517535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Research Network of Computational and Structural Biotechnology |
record_format | MEDLINE/PubMed |
spelling | pubmed-65175352019-05-23 Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy Lu, Shu-Ting Xu, Dan Liao, Ru-Fang Luo, Jia-Zhen Liu, Yu-Hang Qi, Zhen-Hua Zhang, Cai-Ju Ye, Nai-Li Wu, Bo Xu, Hai-Bo Comput Struct Biotechnol J Research Article Single-component nanomaterials such as bismuth (Bi) based on nanoparticles (NPs) intrinsically having both diagnostic and therapeutic capabilities are widely needed in biomedical fields. However, their design and fabrication still face enormous challenges. Here, a kind of pure Bi NPs with ultrahigh X-ray attenuation coeffcient was developed and evaluated as a simple but powerful theranostic nanomaterals and potent light-to-heat conversion efficiency for photoacuostic imaging (PAI)/photothermal therapy (PTT) in this study. The prepared pure Bi NPs showed excellent photothermal performance and the temperature of NPs solution (1 mg/mL) increased to 70 °C under near-infrared light irradiation within 4 min. The pure Bi NPs showed obvious enhancement effect both in X-ray computed tomography (CT) and PA imaging modalities in vivo. In addition, the glioma growth was efficiently suppressed by the pure Bi NPs after 808 nm laser irradiation, while maintained the biosafety and low toxicity. Thus, it is notable that this type of Bi nanomaterial has great potential in multi-imaging guided cancer treatment. Research Network of Computational and Structural Biotechnology 2019-04-13 /pmc/articles/PMC6517535/ /pubmed/31193098 http://dx.doi.org/10.1016/j.csbj.2019.04.005 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Lu, Shu-Ting Xu, Dan Liao, Ru-Fang Luo, Jia-Zhen Liu, Yu-Hang Qi, Zhen-Hua Zhang, Cai-Ju Ye, Nai-Li Wu, Bo Xu, Hai-Bo Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy |
title | Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy |
title_full | Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy |
title_fullStr | Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy |
title_full_unstemmed | Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy |
title_short | Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy |
title_sort | single-component bismuth nanoparticles as a theranostic agent for multimodal imaging-guided glioma therapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517535/ https://www.ncbi.nlm.nih.gov/pubmed/31193098 http://dx.doi.org/10.1016/j.csbj.2019.04.005 |
work_keys_str_mv | AT lushuting singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy AT xudan singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy AT liaorufang singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy AT luojiazhen singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy AT liuyuhang singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy AT qizhenhua singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy AT zhangcaiju singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy AT yenaili singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy AT wubo singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy AT xuhaibo singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy |